In the present study, we identified IRF4, a master player in plasma cell differentiation,26 immune cell proliferation and cell survival,27 as a novel transcription factor for SOX9, demonstrating an association between SOX9 induction and BCL2 rearrangement in a small DLBCL subset. This evidence concerns the gene IRF4 and diffuse large B-cell lymphoma.